BACKGROUND: Respiratory syncytial virus (RSV)-induced diseases are mediated through active cytokines released during infection. We hypothesized that RSV infection causes bronchial epithelial monolayer permeability in vitro via induction of vascular endothelial growth factor (VEGF). METHODS: Human bronchial epithelial cells were infected with RSV. In some cultures, VEGF antibody was included to block VEGF response; in other cultures, palivizumab was added to block RSV infection. Permeability was assessed in real-time using electric cell-substrate impedance sensing. VEGF release was assessed using enzyme-linked immunosorbent assay. Gap formation was assessed using live cell imaging. RESULTS: RSV-infected cells demonstrated a decrease in the resistance of the monolayer indicating an increase in permeability; this increase was blocked with VEGF-specific antibody, and palivizumab. Intercellular gap formation developed in RSV-infected epithelial monolayers. CONCLUSION: RSV increases permeability of the bronchial airway epithelial monolayer via VEGF induction.
BACKGROUND:Respiratory syncytial virus (RSV)-induced diseases are mediated through active cytokines released during infection. We hypothesized that RSV infection causes bronchial epithelial monolayer permeability in vitro via induction of vascular endothelial growth factor (VEGF). METHODS:Human bronchial epithelial cells were infected with RSV. In some cultures, VEGF antibody was included to block VEGF response; in other cultures, palivizumab was added to block RSV infection. Permeability was assessed in real-time using electric cell-substrate impedance sensing. VEGF release was assessed using enzyme-linked immunosorbent assay. Gap formation was assessed using live cell imaging. RESULTS:RSV-infected cells demonstrated a decrease in the resistance of the monolayer indicating an increase in permeability; this increase was blocked with VEGF-specific antibody, and palivizumab. Intercellular gap formation developed in RSV-infected epithelial monolayers. CONCLUSION:RSV increases permeability of the bronchial airway epithelial monolayer via VEGF induction.
Authors: Samantha M Simet; Todd A Wyatt; Jane DeVasure; Daniel Yanov; Diane Allen-Gipson; Joseph H Sisson Journal: Alcohol Clin Exp Res Date: 2011-09-26 Impact factor: 3.455
Authors: Julia Eckardt-Michel; Markus Lorek; Diane Baxmann; Thomas Grunwald; Günther M Keil; Gert Zimmer Journal: J Virol Date: 2008-01-23 Impact factor: 5.103
Authors: Yuh-Chin T Huang; Zhuowei Li; Xhevahire Hyseni; Michael Schmitt; Robert B Devlin; Edward D Karoly; Joleen M Soukup Journal: Genomic Med Date: 2009-05-15
Authors: Raquel Almansa; Andres Anton; Paula Ramirez; Ignacio Martin-Loeches; David Banner; Tomás Pumarola; Luoling Xu; Jesús Blanco; Longsi Ran; Guillermo Lopez-Campos; Fernando Martin-Sanchez; Lorenzo Socias; Ana Loza; David Andaluz; Enrique Maravi; Mónica Gordón; Maria C Gallegos; Victoria Fernandez; Cristobal León; Pedro Merino; Maria Angeles Marcos; Francisco Gandía; Felipe Bobillo; Salvador Resino; Jose M Eiros; Carmen Castro; Paula Mateo; Milagros Gonzalez-Rivera; Jordi Rello; Raul Ortiz de Lejarazu; David J Kelvin; Jesus F Bermejo-Martin Journal: BMC Infect Dis Date: 2011-08-31 Impact factor: 3.090
Authors: Rachel A Collins; Rosa C Gualano; Graeme R Zosky; Constance L Atkins; Debra J Turner; Giuseppe N Colasurdo; Peter D Sly Journal: Respir Res Date: 2005-12-05